Updated Jul 16, 2026
Banerjee Subhashis has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $63K.
Subhashis Banerjee is associated with Artiva Biotherapeutics, Inc., a company focused on developing innovative therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented in public sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ARTV | Artiva Biotherapeutics, Inc. | S — Open-market sale | 7.0K | $9.01 | $63K |
| 2026-02-18 | ARTV | Artiva Biotherapeutics, Inc. | A — Grant or award | 102.0K | $0.00 |
Subhashis Banerjee is associated with Artiva Biotherapeutics, Inc., a company focused on developing innovative therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented in public sources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($63K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Banerjee Subhashis profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.